Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: An autoradiographic study

Brain Research

Volumn 1345, Issue , 2010, Pages 28-44

  Sato, Hiroki ^a,c   Skelin, Ivan ^a,d   Diksic, Mirko ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

5 HT receptors; 5 HT transporter; Autoradiography; Buspirone; Olfactory bulbectomy; Serotonin

Indexed keywords

BUSPIRONE; KETANSERIN; PAROXETINE; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SODIUM CHLORIDE; SEROTONIN 2 AGONIST; SEROTONIN AGONIST; SLC6A4 PROTEIN, RAT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; DENSITY; DEPRESSION; EX VIVO STUDY; MALE; NONHUMAN; OLFACTORY BULBECTOMY; PINEAL BODY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SHAM PROCEDURE; ANIMAL; BRAIN; DEPRESSIVE DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; INFUSION PUMP; METABOLISM; OLFACTORY BULB; RANDOMIZATION; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BUSPIRONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSION PUMPS, IMPLANTABLE; MALE; OLFACTORY BULB; PINEAL GLAND; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN AGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TIME FACTORS; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN RECEPTOR AGONISTS;

ANIMALIA; RATTUS;

EID: 77955515989     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.05.054     Document Type: Article

References (86)

1. I.M. Al-Khatib, M. Fujiwara, Y. Kataoka, and S. Ueki Changes in [3H]-imipramine binding sites in relation to muricide following olfactory bulbectomy and the effect of nomifensine in brain of rats Arch. Int. Pharmacodyn. Thér. 296 1988 282 292
2. D. Benjamin, H. Lal, and L.R. Meyerson The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze Life Sci. 47 3 1990 195 203
3. S. Benmansour, M. Cecchi, D.A. Morilak, G.A. Gerhardt, M.A. Javors, G.G. Gould, and A. Frazer Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level J. Neurosci. 19 1999 10494 10501
4. Z. Bhagwagar, R. Hinz, M. Taylor, S. Fancy, P. Cowen, and P. Grasby Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100, 907 Am. J. Psychiatry 163 9 2006 1580 1587
5. Z. Bhagwagar, N. Murthy, S. Selvaraj, R. Hinz, M. Taylor, S. Fancy, P. Grasby, and P. Cowen 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB Am. J. Psychiatry 164 2007 1858 1865
6. F. Biver, D. Wikler, F. Lotstra, P. Damhaut, S. Goldman, and J. Mendlewicz Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex Br. J. Psychiatry 171 1997 444 448
7. P. Blier, and C. de Montigny Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies J. Clin. Psychopharmacol. 10 3 Suppl 1990 13S 20S
8. P. Blier, C. de Montigny, and Y. Chaput Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission. Clinical Neuropharmacology 11 Suppl 2 1988 S1 10
9. P. Blier, and C. de Montigny Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders Neuropsychopharmacology 21 2 Suppl 1999 91S 98S Review
10. P. Blier, A. Lista, and C. De Montigny Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins J. Pharmacol. Exp. Ther. 265 1993 16 23 (Pubitemid 23320936)
11. J. Butler, M. Tannian, and B.E. Leonard The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats Prog. Neuropsychopharmacol. Biol. Psychiatry 12 5 1988 585 594
12. S. Caccia, I. Conti, G. Vigano, and S. Garattini 1-(2-Pyrimidinyl)- piperazine as active metabolite of buspirone in man and rat Pharmacology 33 1986 46 51
13. K.D. Cairncross, B. Cox, C. Forster, and A.F. Wren Olfactory projection systems, drugs and behaviour: a review Psychoneuroendocrinology 4 3 1979 253 272
14. D.M. Cannon, M. Ichise, D. Rollis, J.M. Klaver, S.K. Gandhi, D.S. Charney, H.K. Manji, and W.C. Drevets Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder Biol. Psychiatry 62 8 2007 870 877
15. J.C. Cassel, H. Jeltsch, B. Neufang, D. Lauth, B. Szabo, and R. Jackisch Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin Brain Res. 704 2 1995 153 166
16. M.S. Clark, T.J. Sexton, M. McClain, D. Root, R. Kohen, and J.F. Neumaier Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress J. Neurosci. 22 11 2002 4550 4562
17. W.M. Cowan, G. Raisman, and T.P. Powell The connexions of the amygdala J. Neurol. Neurosurg. Psychiatry 28 1965 137 151
18. M.A. Critchley, K. Njung'e, and S.L. Handley Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions Psychopharmacology (Berlin) 106 4 1992 484 490
19. C. Davidson, and J.A. Stamford The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT1A and 5-HT1B/D receptor antagonists Neurosci. Lett. 188 1 1995 41 44
20. M. De Vivo, and S. Maayani Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes J. Pharmacol. Exp. Ther. 238 1986 248 253
21. B. Earley, M. Glennon, M. Lally, B.E. Leonard, and J.L. Junien Autoradiographic distribution of cholinergic muscarinic receptors and serotonin (2) receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine Hum. Psychopharmacol. 9 1994 397 407
22. S. Esteban, J. Llado, A. Sastre-Coll, and J.A. Garcia-Sevilla Activation and desensitization by cyclic antidepressant drugs of α2-autoreceptors, α2-heteroceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo Naunyn-Schmiedebergs Arch. Pharmacol. 360 1999 135 143
23. L.F. Fabre Buspirone in the management of major depression: a placebo-controlled comparison J. Clin. Psychiatry 51 Suppl 1990 55 61
24. R.W. Fuller, and D. Wong Serotonin uptake and serotonin uptake inhibition Ann. NY Acad. Sci. 600 1990 68 78 discussion 79-80. Review
25. M. Gobbi, D. Crespi, M.C. Foddi, C. Fracasso, L. Mancini, L. Parotti, and T. Mennini Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn-Schmiedebergs. Arch. Pharmacol 356 1 1997 22 28
26. H.L. Goldberg, and R. Finnerty Comparison of buspirone in two separate studies. J. Clin. Psychiatry 43 1982 87 91
27. G.G. Gould, M.A. Javors, and A. Frazer Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain Biol. Psychiatry 61 2 2007 210 215
28. G. Grecksch, D. Zhou, C. Franke, U. Schröder, B Sabel, A. Becker, and G. Huether Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br. J. Pharmacol. 122 8 1997 1725 1731
29. L.B. Haberly, and J.L. Price Association and commissural fiber systems of the olfactory cortex of the rat J. Comp. Neurol. 178 4 1978 711 740
30. E. Habert, D. Graham, L. Tahraoui, Y. Claustre, and S.Z. Langer Characterization of [3H]paroxetine binding to rat cortical membranes Eur. J. Pharmacol. 118 1-2 1985 107 114
31. F. Han, N. Shioda, S. Moriguchi, Z.H. Qin, and K. Fukunaga The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice Neuroscience 151 3 2008 671 679
32. S. Hasegawa, A. Watanabe, K. Nguyen, G. Debonnel, and M. Diksic Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study Psychopharmacology (Berl) 179 4 2005 781 790
33. D. Hoyer, and H.W. Boddeke Partial agonists, full agonists, antagonists: dilemmas of definition Trends Pharmacol. Sci. 14 1993 270 275
34. P.D. Hrdina, and T.B. Vu Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study Synapse 14 4 1993 324 331
35. J.A. Jesberger, and J.S. Richardson Effects of antidepressant drugs on the behavior of olfactory bulbectomized and sham-operated rats Behav. Neurosci. 100 2 1986 256 274
36. J.A. Jesberger, and J.S. Richardson Brain output dysregulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans? Int. J. Neurosci. 38 3-4 1988 241 265 Feb
37. T. Jolas, S. Haj-Dahmane, E.J. Kidd, X. Langlois, L. Lanfumey, C.M. Fattaccini, V. Vantalon, A.M. Laporte, J. Adrien, and H. Gozlan Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine J. Pharmacol. Exp. Ther. 268 3 1994 1432 1443
38. L.L. Judd Mood disorders in the general population represent an important and worldwide public health problem Int. Clin. Psychopharmacol., Suppl. 4 1995 5 10 Review. Erratum in: International Clinical Psychopharmacology 11: 153
39. K.J. Kaiyala, E.S. Vincow, T.J. Sexton, and J.F. Neumaier 5-HT1B receptor mRNA levels in dorsal raphe nucleus: inverse association with anxiety behavior in the elevated plus maze. Pharmacol., Biochem. Behav. 75 4 2003 769 776
40. J.P. Kelly, A.S. Wrynn, and B.E. Leonard The olfactory bulbectomized rat as a model of depression: an update Pharmacol. Ther. 74 1997 299 316
41. J.P. Kelly, A. Wrynn, and B.E. Leonard The olfactory bulbectomized rat as a model of depression: an update Pharmacol. Ther. 74 1997 299 316
42. 1A agonists and conventional antidepressants in an animal model of depression Eur. J. Pharmacol. 134 1987 265 274
43. J.P. Kiss Theory of active antidepressants: a nonsynaptic approach to the treatment of depression Neurochem. Int. 52 1-2 2008 34 39
44. J.W. Lance 5-Hydroxytryptamine and its role in migraine Eur. Neurol. 31 5 1991 279 281 Review
45. I. Lucki, A. Singh, and D.S. Kreiss Antidepressant-like behavioral effects of serotonin receptor agonists Neurosci. Biobehav. Rev. 18 1994 85 95
46. A.R. Lumia, M.H. Teicher, F. Salchli, E. Ayers, and B. Possidente Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 587 2 1992 181 185
47. I. Makkonen, R. Riikonen, H. Kokki, M.M. Airaksinen, and J.T. Kuikka Serotonin and dopamine transporter binding in children with autism determined by SPECT Dev. Med. Child Neurol. 50 8 2008 593 597
48. H.S. Mayberg Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment Br. Med. Bull. 65 2003 193 207
49. C.C. Meltzer, J.C. Price, C.A. Mathis, P.J. Greer, M.N. Cantwell, P.R. Houck, B.H. Mulsant, D. Ben-Eliezer, B. Lopresti, S.T. DeKosky, and C.F. Reynolds III PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders Am. J. Psychiatry 156 12 1999 1871 1878
50. J.H. Meyer, R. Cho, S. Kennedy, and S. Kapur The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET Psychopharmacology (Berlin) 144 3 1999 279 281
51. J.H. Meyer, S. Kapur, B. Eisfeld, G.M. Brown, S. Houle, J. DaSilva, A.A. Wilson, S. Rafi-Tari, H.S. Mayberg, and S.H. Kennedy The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study Am. J. Psychiatry 158 1 2001 78 85
52. J.H. Meyer, S. McMain, S.H. Kennedy, L. Korman, G.M. Brown, J.N. DaSilva, A.A. Wilson, T. Blak, R. Eynan-Harvey, V.S. Goulding, S. Houle, and P. Links Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am. J. Psychiatry 160 1 2003 90 99
53. J.H. Meyer, S. Houle, S. Sagrati, A. Carella, D.F. Hussey, N. Ginovart, V. Goulding, J. Kennedy, and A.A. Wilson Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes Arch. Gen. Psychiatry 61 12 2004 1271 1279
54. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
55. J.F. Neumaier, D.C. Root, and M.W. Hamblin Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus Neuropsychopharmacology 15 5 1996 515 522
56. D.E. Nichols, and C.D. Nichols Serotonin receptors Chem. Rev. 108 5 2008 1614 1641
57. K. Nishi, K. Kanemaru, and M. Diksic A genetic rat model of depression, Flinders sensitive line has a lower density of 5-HT1A receptors, but a higher density of 5-HT1B receptors, compared to control rats Neurochem. Int. 54 5-6 2009 299 307
58. S.D. Norrholm, D.B. Horton, and L.P. Dwoskin The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes Neuropharmacology 53 8 2007 982 989
59. J.J. O'Connor, M.J. Rowan, and R. Anwyl Long-lasting enhancement of NMDA receptor-mediated synaptic transmission by metabotropic glutamate receptor activation Nature 367 6463 1994 557 559
60. S.J. O'Dell, G.J. La Hoste, C.B. Widmark, R.M. Shapiro, S.G. Potkin, and J.F. Marshall Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain Synapse 6 2 1990 146 153
61. G. Paxinos, and C. Watson The Rat Brain Atlas in Stereotaxic Coordinates 1997 Compact Third Edition; Academic Press New York
62. A. Pazos, and J.M. Palacios Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors Brain Res. 346 2 1985 205 230 (Pubitemid 16241111)
63. A. Pazos, A. Probst, and J.M. Palacios Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors Neuroscience 21 1 1987 123 139 (Pubitemid 17076867)
64. S. Pellow, A.L. Johnston, and S.E. File Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat J. Pharm. Pharmacol. 39 11 1987 917 928
65. M.L. Phillips, W.C. Drevets, S.L. Rauch, and R. Lane Neurobiology of emotion perception II: Implications for major psychiatric disorders Biol. Psychiatry 54 2003 515 528
66. M.F. Piercey, M.W. Smith, and J.T. Lum-Ragan Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties J. Pharmacol. Exp. Ther. 268 3 1994 1297 1303
67. N.H. Raskin Serotonin receptors and headache N Engl J. Med. 325 5 1991 353 354
68. M. Reimold, A. Batra, A. Knobel, M.N. Smolka, A. Zimmer, K. Mann, C. Solbach, G. Reischl, F. Schwärzler, G. Gründer, H.J. Machulla, R. Bares, and A. Heinz Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study Mol. Psychiatry 13 6 2008 606 613
69. G. Rudnick, and J. Clark From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters Biochim. Biophys. Acta 1144 3 1993 249 263 Review
70. Y. Sakai, C. Dobson, M. Diksic, M. Aubé, and E. Hamel Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis Neurology 70 6 2008 431 439
71. Y. Sari Serotonin1B receptors: from protein to physiological function and behavior Neurosci. Biobehav. Rev. 28 6 2004 565 582 Review
72. H. Sato, I. Skelin, G. Debonnel, and M. Diksic Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites Brain Res. Bull. 75 5 2008 545 555
73. F. Saudou, D.A. Amara, A. Dierich, M. LeMeur, S. Ramboz, L. Segu, M.C. Buhot, and R. Hen Enhanced aggressive behavior in mice lacking 5-HT1B receptor Science 265 5180 1994 1875 1878
74. E.E. Schweizer, J. Amsterdam, K. Rickels, M. Kaplan, and M. Droba Open trial of buspirone in the treatment of major depressive disorder Psychopharmacol. Bull. 22 1986 183 185
75. J.C. Soares, and J.J. Mann The functional neuroanatomy of mood disorders J. Psychiatr. Res. 31 1997 393 432
76. C. Song, and B.E. Leonard Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. Neuroimmunomodulation 2 5 1995 263 273
77. C. Song, and B.E. Leonard The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 29 4-5 2005 627 647
78. C.H. van Dyck, J.C. Soares, P.Z. Tan, J.K. Staley, R.M. Baldwin, L.A. Amici, X. Fu, P.K. Garg, J.P. Seibyl, D.S. Charney, and R.B. Innis Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm Nucl. Med. Biol. 27 8 2000 715 722
79. H. van Riezen, and B.E. Leonard Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol. Ther. 47 1990 21 34
80. A. Watanabe, Y. Tohyama, K.Q. Nguyen, S. Hasegawa, G. Debonnel, and M. Diksic Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study J. Neurochem. 85 2003 469 475
81. A. Watanabe, S. Hasegawa, K. Nishi, K.Q. Nguyen, and M. Diksic Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: An autoradiographic study Brain Res. Bull. 69 2006 101 108
82. P. Willner Animal models of depression: an overview. Pharmacol. Ther. 45 3 1990 425 455
83. P. Willner, and P.J. Mitchell The validity of animal models of predisposition to depression Behav. Pharmacol. 13 2002 169 188
84. L.N. Yatham, P.F. Liddle, J. Dennie, I.S. Shiah, M.J. Adam, C.J. Lane, R.W. Lam, and T.J. Ruth Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone Arch. Gen. Psychiatry 56 8 1999 705 711
85. H. Yoshimura, and S. Ueki Biochemical correlates in mouse-killing behavior of the rat: prolonged isolation and brain cholinergic function. Pharmacol., Biochem. Behav. 6 2 1977 193 196
86. D. Zhou, G. Grecksch, A. Becker, C. Frank, J. Pilz, and G. Huether Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat J. Neurosci. Res. 54 1998 109 116